Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GWC Technologies is a private life science tools company based in Madison, Wisconsin that develops and manufactures label-free analytical instrumentation for proteomics, drug discovery, genomics, diagnostics development, and broader life science research. The company is best known for its surface plasmon resonance imaging (SPRi) systems, including the SPRimager II platform, as well as related biosensor chips and consumables such as SpotReady surfaces. Its products enable real-time, label-free analysis of molecular interactions in array formats, supporting applications such as protein interaction analysis, membrane and receptor studies, and assay development. GWC also serves some materials science use cases, but its core commercial identity is as a biosensor and scientific instrumentation company rather than a therapeutics developer. The company appears to operate as a niche, commercially active provider of research tools rather than as a clinical-stage biotech with a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GWC Technologies.